194 related articles for article (PubMed ID: 34385977)
41. Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer.
Kasemsiri P; Chaisakgreenon P; Vatanasapt P; Laohasiriwong S; Teeramatwanich W; Thongrong C; Ratanaanekchai T; Suetrong S
Int J Surg Oncol; 2021; 2021():5545127. PubMed ID: 34123423
[TBL] [Abstract][Full Text] [Related]
42. Anaplastic thyroid carcinoma with rhabdoid phenotype: An unusual case and a comprehensive review.
Bansal S; Sancheti S; Kaur S; Somal P; Kalra SK; Sali AP
Diagn Cytopathol; 2020 Nov; 48(11):1125-1130. PubMed ID: 32515545
[TBL] [Abstract][Full Text] [Related]
43. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
44. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
45. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.
Sun C; Li Q; Hu Z; He J; Li C; Li G; Tao X; Yang A
PLoS One; 2013; 8(11):e80011. PubMed ID: 24224029
[TBL] [Abstract][Full Text] [Related]
46. Impact of Local Control on Clinical Course in Stage IVC Anaplastic Thyroid Carcinoma.
Yamazaki H; Sugino K; Katoh R; Masudo K; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Ito K
World J Surg; 2022 Dec; 46(12):3034-3042. PubMed ID: 36127501
[TBL] [Abstract][Full Text] [Related]
47. Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case.
Juhlin CC; Höög A
Int J Surg Pathol; 2019 Sep; 27(6):658-663. PubMed ID: 30931661
[TBL] [Abstract][Full Text] [Related]
48. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
49. Anaplastic Transformation of Differentiated Thyroid Carcinoma.
Yu AC; Han AY; Cronkite DA; Sajed D; St John MA
Laryngoscope; 2023 Feb; 133(2):437-442. PubMed ID: 35779253
[TBL] [Abstract][Full Text] [Related]
50. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
[TBL] [Abstract][Full Text] [Related]
51. Survival and prognostic factors of anaplastic thyroid carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
[TBL] [Abstract][Full Text] [Related]
52. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
53. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
[TBL] [Abstract][Full Text] [Related]
54. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
[TBL] [Abstract][Full Text] [Related]
55. Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma.
Cho S; Kim H; Oh YL; Hahn SY; Kim TH; Shin JH
Sci Rep; 2023 Feb; 13(1):3264. PubMed ID: 36828842
[TBL] [Abstract][Full Text] [Related]
56. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
[TBL] [Abstract][Full Text] [Related]
57. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
58. Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report.
Liu J; Cui N; Ding W; Dong X; Chen X; Jiang J; Liu Y
Diagn Pathol; 2020 Jul; 15(1):89. PubMed ID: 32693811
[TBL] [Abstract][Full Text] [Related]
59. Anaplastic thyroid carcinoma in Denmark 1996-2012: A national prospective study of 219 patients.
Hvilsom GB; Londero SC; Hahn CH; Schytte S; Pedersen HB; Christiansen P; Kiss K; Larsen SR; Jespersen ML; Lelkaitis G; Godballe C
Cancer Epidemiol; 2018 Apr; 53():65-71. PubMed ID: 29414634
[TBL] [Abstract][Full Text] [Related]
60. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
